The University of Chicago Header Logo

Connection

Eric Pamer to Hematopoietic Stem Cell Transplantation

Back to Details
This is a "connection" page, showing publications Eric Pamer has written about Hematopoietic Stem Cell Transplantation.
Eric Pamer
Connection Strength
4.027
Hematopoietic Stem Cell Transplantation
  1. Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation. Am J Respir Crit Care Med. 2016 08 15; 194(4):450-63.
    View in: PubMed
    Score: 0.326
  2. Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol. 2015 Jun-Sep; 28(2-3):155-61.
    View in: PubMed
    Score: 0.308
  3. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014 Aug 14; 124(7):1174-82.
    View in: PubMed
    Score: 0.280
  4. Cuffed and exposed--perp-walking bradyrhizobium. N Engl J Med. 2013 Aug 08; 369(6):572-4.
    View in: PubMed
    Score: 0.264
  5. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med. 2013 Mar; 19(3):372-7.
    View in: PubMed
    Score: 0.256
  6. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012 Oct; 55(7):905-14.
    View in: PubMed
    Score: 0.244
  7. TLR polymorphisms and the risk of invasive fungal infections. N Engl J Med. 2008 Oct 23; 359(17):1836-8.
    View in: PubMed
    Score: 0.190
  8. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients. Cell. 2023 06 08; 186(12):2705-2718.e17.
    View in: PubMed
    Score: 0.131
  9. A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients. Sci Data. 2022 05 18; 9(1):219.
    View in: PubMed
    Score: 0.121
  10. Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria. Clin Infect Dis. 2021 12 06; 73(11):e4627-e4635.
    View in: PubMed
    Score: 0.118
  11. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood. 2021 03 18; 137(11):1527-1537.
    View in: PubMed
    Score: 0.112
  12. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients. Sci Data. 2021 03 02; 8(1):71.
    View in: PubMed
    Score: 0.112
  13. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood. 2000 Oct 15; 96(8):2814-21.
    View in: PubMed
    Score: 0.109
  14. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020 02 27; 382(9):822-834.
    View in: PubMed
    Score: 0.104
  15. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019 11 29; 366(6469):1143-1149.
    View in: PubMed
    Score: 0.102
  16. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018 06 28; 131(26):2978-2986.
    View in: PubMed
    Score: 0.091
  17. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv. 2018 04 10; 2(7):745-753.
    View in: PubMed
    Score: 0.091
  18. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis. 2017 04 01; 215(7):1117-1123.
    View in: PubMed
    Score: 0.085
  19. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol. 2017 May 20; 35(15):1650-1659.
    View in: PubMed
    Score: 0.085
  20. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016 05 18; 8(339):339ra71.
    View in: PubMed
    Score: 0.080
  21. Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant. Infect Control Hosp Epidemiol. 2016 Jan; 37(1):8-15.
    View in: PubMed
    Score: 0.077
  22. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One. 2014; 9(3):e90158.
    View in: PubMed
    Score: 0.069
  23. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010 Dec; 120(12):4332-41.
    View in: PubMed
    Score: 0.055
  24. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010 Nov; 16(11):1576-81.
    View in: PubMed
    Score: 0.053
  25. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010 Apr; 60(4):257-63.
    View in: PubMed
    Score: 0.052
  26. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J Immunol. 2009 Aug 15; 183(4):2678-87.
    View in: PubMed
    Score: 0.050
  27. Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study. Biol Blood Marrow Transplant. 2009 Sep; 15(9):1130-3.
    View in: PubMed
    Score: 0.050
  28. Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a single-institution, nested case-controlled study. Biol Blood Marrow Transplant. 2008 Dec; 14(12):1429-33.
    View in: PubMed
    Score: 0.048
  29. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis. 2008 Jun; 10(3):162-7.
    View in: PubMed
    Score: 0.043
  30. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis. 2007 Jun; 9(2):108-13.
    View in: PubMed
    Score: 0.043
  31. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2007 Dec; 9(4):286-94.
    View in: PubMed
    Score: 0.043
  32. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med. 2006 Sep; 12(9):1039-47.
    View in: PubMed
    Score: 0.041
  33. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci. 2005 Dec; 1062:95-103.
    View in: PubMed
    Score: 0.039
  34. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005 Mar; 7(1):11-7.
    View in: PubMed
    Score: 0.037
  35. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study. Clin Infect Dis. 2004 Dec 01; 39(11):1625-32.
    View in: PubMed
    Score: 0.036
  36. Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood. 2003 Jun 01; 101(11):4290-7.
    View in: PubMed
    Score: 0.032
  37. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood. 2020 07 02; 136(1):130-136.
    View in: PubMed
    Score: 0.027
  38. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med. 2018 09 26; 10(460).
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.